Valuation: Abbott Laboratories

Market Cap 187B 162B 151B 138B 260B 17,777B 264B 1,769B 694B 8,896B 700B 685B 29,705B P/E 2026 *
31.2x
P/E 2027 * 24x
Enterprise Value 211B 183B 171B 156B 294B 20,079B 299B 1,998B 784B 10,048B 791B 774B 33,553B EV / Sales 2026 *
4.19x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.37%
Yield 2027 * 2.5%
1 day+1.93%
3 months+1.93%
6 months-19.97%
Current year-30.19%
Current year 72.68
Extreme 72.68
98.39
1 year 72.68
Extreme 72.68
98.39
3 years 72.68
Extreme 72.68
110.91
5 years 72.68
Extreme 72.68
110.91
10 years 72.68
Extreme 72.68
110.91
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.93%-.--% - - 187B
+0.75%+2.76%-19.11%+3.15% 187B
+2.58%+4.71%-3.74%+7.80% 112B
+1.42%+4.39%+13.98%+75.00% 61.15B
+2.38%+6.38%+35.52%+59.33% 54.39B
+1.57%+8.46%-7.17%-36.20% 48.17B
+3.42%+5.03%+11.15%-21.01% 31.98B
-4.03%-13.93% - - 30.91B
-0.55%+3.28%+46.12%-12.00% 24.92B
+0.61%+4.60%-1.62%+5.26% 23.15B
Average +1.01%+0.50%+9.39%+10.17% 63.64B
Weighted average by Cap. +1.40%+2.08%-0.13%+12.33%

Financials

2026 *2027 *
Net sales 50.3B 43.58B 40.75B 37.24B 70.1B 4,793B 71.3B 477B 187B 2,399B 189B 185B 8,010B 54.65B 47.34B 44.27B 40.45B 76.15B 5,207B 77.45B 518B 203B 2,606B 205B 201B 8,702B
Net income 6.23B 5.4B 5.05B 4.61B 8.68B 594B 8.83B 59.07B 23.19B 297B 23.39B 22.88B 992B 7.93B 6.87B 6.43B 5.87B 11.06B 756B 11.25B 75.23B 29.54B 378B 29.78B 29.14B 1,263B
Net Debt 24.17B 20.93B 19.58B 17.89B 33.67B 2,303B 34.25B 229B 89.95B 1,152B 90.71B 88.76B 3,848B 21.42B 18.55B 17.35B 15.85B 29.84B 2,041B 30.35B 203B 79.72B 1,021B 80.39B 78.66B 3,410B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
107.81USD
Average target price
118.42USD
Spread / Average Target
+9.84%

Quarterly revenue - Rate of surprise